117 related articles for article (PubMed ID: 579492)
1. Heparinised clotting factor concentrates in patients with Christmas disease and liver disease.
Preston FE; Malia RG; Lilleyman JS; Blackburn EK
Thromb Haemost; 1977 Aug; 38(2):504-9. PubMed ID: 579492
[TBL] [Abstract][Full Text] [Related]
2. Serial changes in the coagulation system following clotting factor concentrate infusion.
Preston FE; Winfield DA; Malia RG; Blackburn EK
Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
[TBL] [Abstract][Full Text] [Related]
3. High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC.
Philippou H; Adami A; Lane DA; MacGregor IR; Tuddenham EG; Lowe GD; Rumley A; Ludlam CA
Thromb Haemost; 1996 Jul; 76(1):23-8. PubMed ID: 8819246
[TBL] [Abstract][Full Text] [Related]
4. [Summary of work session 1: Blood coagulation in gastroenterology].
Bredden K; Lechner K
Z Gastroenterol; 1976 Mar; 14 Suppl():202-10. PubMed ID: 785839
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic liver transplantation for hepatitis C infection: the best Christmas present?
Johnston SD; McNulty O; Mayne E; Callender ME
Ulster Med J; 1998 Nov; 67(2):134-6. PubMed ID: 9885554
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
Ruiz-Sáez A; Hong A; Arguello A; Echenagucia M; Boadas A; Fabbrizzi F; Minichilli F; Bosch NB
Haemophilia; 2005 Nov; 11(6):583-8. PubMed ID: 16236107
[TBL] [Abstract][Full Text] [Related]
7. Intravascular coagulation in surgical procedures on the abdominal aorta.
Mulcare RJ; Royster TS; Phillips LL
Surg Gynecol Obstet; 1976 Nov; 143(5):730-4. PubMed ID: 982252
[TBL] [Abstract][Full Text] [Related]
8. [Blood platelets of hemophilia patients].
Weibbbach G; Bührdel P; Domula M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
[No Abstract] [Full Text] [Related]
9. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
Négrier C; Menart C; Attali O; Petit PY; Lienhart A; Dechavanne M; Ingerslev J
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S135-41. PubMed ID: 9819045
[TBL] [Abstract][Full Text] [Related]
10. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
12. Some aspects of coagulation and fibrinolysis in non-pregnant and pregnant Zambians.
Chatterjee TK; Traub N
Med J Zambia; 1978; 12(2):40-2. PubMed ID: 726651
[TBL] [Abstract][Full Text] [Related]
13. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
Girolami A; Scandellari R; Scapin M; Vettore S
Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
[TBL] [Abstract][Full Text] [Related]
14. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
Hillenbrand P; Parbhoo SP; Jedrychowski A; Sherlock S
Scand J Gastroenterol Suppl; 1973; 19():133-4. PubMed ID: 4515635
[No Abstract] [Full Text] [Related]
15. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
16. Does coagulation have a causative role in eclampsia?
Pritchard JA; Cunningham FG; Mason RA
Perspect Nephrol Hypertens; 1976; 5():95-102. PubMed ID: 1005057
[TBL] [Abstract][Full Text] [Related]
17. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
Bańkowski E; Worowski K
Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
[No Abstract] [Full Text] [Related]
18. Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
Gazzard BG; Lewis ML; Ash G; Rizza CR; Bidwell E; Williams R
Gut; 1974 Dec; 15(12):993-8. PubMed ID: 4448416
[TBL] [Abstract][Full Text] [Related]
19. Blood clotting abnormalities in liver disease.
Aledort LM
Prog Liver Dis; 1976; 5():350-62. PubMed ID: 775547
[No Abstract] [Full Text] [Related]
20. Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates.
Hanley JP; Jarvis LM; Hayes PC; Lee AJ; Simmonds P; Ludlam CA
Thromb Haemost; 1998 Feb; 79(2):291-5. PubMed ID: 9493578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
